| Year |
Citation |
Score |
| 2023 |
Wazahat R, Juneja P, Chauhan V, Zaidi R, Lamichhane G, Singh UB, Haider M, Kumar P. A strip-based assay for detection of CrfA enzyme activity to differentiate Mycobacterium tuberculosis and non-tuberculous mycobacteria. Journal of Microbiological Methods. 211: 106781. PMID 37437716 DOI: 10.1016/j.mimet.2023.106781 |
0.643 |
|
| 2022 |
Ahmad N, Dugad S, Chauhan V, Ahmed S, Sharma K, Kachhap S, Zaidi R, Bishai WR, Lamichhane G, Kumar P. Allosteric cooperation in ß-lactam binding to a non-classical transpeptidase. Elife. 11. PMID 35475970 DOI: 10.7554/eLife.73055 |
0.672 |
|
| 2022 |
Galanis C, Maggioncalda EC, Kumar P, Lamichhane G. Glby, Encoded by , Is Required for Growth of Mycobacteroides abscessus and Exhibits Mild β-Lactamase Activity. Journal of Bacteriology. e0004622. PMID 35380462 DOI: 10.1128/jb.00046-22 |
0.527 |
|
| 2022 |
De Jager V, Gupte N, Nunes S, Barnes GL, van Wijk RC, Mostert J, Dorman SE, Abulfathi AA, Upton CM, Faraj A, Nuermberger EL, Lamichhane G, Svensson EM, Simonsson U, Diacon AH, et al. Early Bactericidal Activity of Meropenem Plus Clavulanate (+/-Rifampin) For TB: The COMRADE Randomized, Phase 2 Trial. American Journal of Respiratory and Critical Care Medicine. PMID 35258443 DOI: 10.1164/rccm.202108-1976OC |
0.322 |
|
| 2022 |
Kumar G, Galanis C, Batchelder HR, Townsend CA, Lamichhane G. Penicillin Binding Proteins and β-Lactamases of Mycobacterium tuberculosis: Reexamination of the Historical Paradigm. Msphere. 7: e0003922. PMID 35196121 DOI: 10.1128/msphere.00039-22 |
0.394 |
|
| 2022 |
Nicklas DA, Maggioncalda EC, Story-Roller E, Eichelman B, Tabor C, Serio AW, Keepers TR, Chitra S, Lamichhane G. Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates and in a Mouse Model of Pulmonary Infection. Antimicrobial Agents and Chemotherapy. 66: e0170421. PMID 34662184 DOI: 10.1128/AAC.01704-21 |
0.333 |
|
| 2021 |
Jadhav R, Gallardo-Macias R, Kumar G, Daher SS, Kaushik A, Bigelow KM, Nuermberger EL, Lamichhane G, Freundlich JS. Assessment of carbapenems in a mouse model of Mycobacterium tuberculosis infection. Plos One. 16: e0249841. PMID 33939697 DOI: 10.1371/journal.pone.0249841 |
0.362 |
|
| 2021 |
Ntombela T, Seupersad A, Maseko S, Ibeji CU, Tolufashe G, Maphumulo SI, Naicker T, Baijnath S, Maguire GEM, Govender T, Lamichhane G, Honarparvar B, Kruger HG. Mechanistic insight on the inhibition of D, D-carboxypeptidase from by -lactam antibiotics: an ONIOM acylation study. Journal of Biomolecular Structure & Dynamics. 1-11. PMID 33719919 DOI: 10.1080/07391102.2021.1899052 |
0.467 |
|
| 2020 |
Batchelder HR, Story-Roller E, Lloyd EP, Kaushik A, Bigelow KM, Maggioncalda EC, Nuermberger EL, Lamichhane G, Townsend CA. Development of a penem antibiotic against Mycobacteroides abscessus. Communications Biology. 3: 741. PMID 33288821 DOI: 10.1038/s42003-020-01475-2 |
0.311 |
|
| 2020 |
Maggioncalda EC, Story-Roller E, Mylius J, Illei P, Basaraba RJ, Lamichhane G. A mouse model of pulmonary Mycobacteroides abscessus infection. Scientific Reports. 10: 3690. PMID 32111900 DOI: 10.1038/S41598-020-60452-1 |
0.402 |
|
| 2019 |
Singh UB, Das R, Shrestha P, Bala K, Pandey P, Verma SK, Gautam H, Story-Roller E, Lamichhane G, Guleria R. Compromised longevity due to pulmonary disease in lungs scarred by tuberculosis. Access Microbiology. 1: e000003. PMID 32974490 DOI: 10.1099/acmi.0.000003 |
0.314 |
|
| 2019 |
Sabe VT, Tolufashe GF, Ibeji CU, Maseko SB, Govender T, Maguire GEM, Lamichhane G, Honarparvar B, Kruger HG. Identification of potent L,D-transpeptidase 5 inhibitors for Mycobacterium tuberculosis as potential anti-TB leads: virtual screening and molecular dynamics simulations. Journal of Molecular Modeling. 25: 328. PMID 31656981 DOI: 10.1007/S00894-019-4196-Z |
0.56 |
|
| 2019 |
Thota N, Makam P, Rajbongshi KK, Nagiah S, Abdul NS, Chuturgoon AA, Kaushik A, Lamichhane G, Somboro AM, Kruger HG, Govender T, Naicker T, Arvidsson PI. -Trifluoromethylthiolated Sulfonimidamides and Sulfoximines: Anti-microbial, Anti-mycobacterial, and Cytotoxic Activity. Acs Medicinal Chemistry Letters. 10: 1457-1461. PMID 31620233 DOI: 10.1021/Acsmedchemlett.9B00285 |
0.522 |
|
| 2019 |
Story-Roller E, Maggioncalda EC, Lamichhane G. Synergistic efficacy of β-lactam combinations against pulmonary infection in mice. Antimicrobial Agents and Chemotherapy. PMID 31109979 DOI: 10.1128/Aac.00614-19 |
0.397 |
|
| 2019 |
Ibeji CU, Lawal MM, Tolufashe GF, Govender T, Naicker T, Maguire GEM, Lamichhane G, Kruger HG, Honarparvar B. The Driving Force for the Acylation of β-Lactam Antibiotics by L,D-Transpeptidase 2: Quantum Mechanics/Molecular Mechanics (QM/MM) Study. Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry. PMID 30969480 DOI: 10.1002/Cphc.201900173 |
0.513 |
|
| 2019 |
Story-Roller E, Maggioncalda EC, Lamichhane G. Select β-lactam combinations exhibit synergy against . Antimicrobial Agents and Chemotherapy. PMID 30745389 DOI: 10.1128/Aac.02613-18 |
0.428 |
|
| 2019 |
Kaushik A, Ammerman NC, Lee J, Martins O, Kreiswirth BN, Lamichhane G, Parrish NM, Nuermberger EL. activity of the new β-lactamase inhibitors relebactam and vaborbactam in combination with β-lactams against complex clinical isolates. Antimicrobial Agents and Chemotherapy. PMID 30642943 DOI: 10.1128/Aac.02623-18 |
0.343 |
|
| 2019 |
Tolufashe GF, Sabe VT, Ibeji CU, Lawal MM, Govender T, Maguire GEM, Lamichhane G, Kruger HG, Honarparvar B. Inhibition mechanism of L,D-transpeptidase 5 in presence of the β-lactams using ONIOM method. Journal of Molecular Graphics & Modelling. 87: 204-210. PMID 30554066 DOI: 10.1016/J.Jmgm.2018.11.009 |
0.669 |
|
| 2018 |
Ibeji CU, Tolufashe GF, Ntombela T, Govender T, Maguire GEM, Lamichhane G, Kruger HG, Honarparvar B. The catalytic role of water in the binding site of l,d-transpeptidase 2 within acylation mechanism: A QM/MM (ONIOM) modelling. Tuberculosis (Edinburgh, Scotland). 113: 222-230. PMID 30514506 DOI: 10.1016/J.Tube.2018.10.005 |
0.608 |
|
| 2018 |
Tolufashe GF, Sabe VT, Ibeji CU, Ntombela T, Govender T, Maguire GEM, Kruger HG, Lamichhane G, Honarparvar B. Structure and function of L,D- and D,D-transpeptidase family enzymes from Mycobacterium tuberculosis. Current Medicinal Chemistry. PMID 30501595 DOI: 10.2174/0929867326666181203150231 |
0.688 |
|
| 2018 |
Story-Roller E, Maggioncalda EC, Cohen KA, Lamichhane G. and β-Lactams: Emerging Insights and Potential Opportunities. Frontiers in Microbiology. 9: 2273. PMID 30319581 DOI: 10.3389/Fmicb.2018.02273 |
0.355 |
|
| 2018 |
Story-Roller E, Lamichhane G. Have we realized the full potential of β-lactams for treating drug-resistant TB? Iubmb Life. PMID 29934998 DOI: 10.1002/Iub.1875 |
0.46 |
|
| 2018 |
Ntombela T, Fakhar Z, Ibeji CU, Govender T, Maguire GEM, Lamichhane G, Kruger HG, Honarparvar B. Molecular insight on the non-covalent interactions between carbapenems and L,D-transpeptidase 2 from Mycobacterium tuberculosis: ONIOM study. Journal of Computer-Aided Molecular Design. PMID 29845435 DOI: 10.1007/S10822-018-0121-2 |
0.607 |
|
| 2018 |
Schwartz M, Fisher S, Story-Roller E, Lamichhane G, Parrish N. Activities of Dual Combinations of Antibiotics Against Multidrug-Resistant Nontuberculous Mycobacteria Recovered from Patients with Cystic Fibrosis. Microbial Drug Resistance (Larchmont, N.Y.). PMID 29368988 DOI: 10.1089/Mdr.2017.0286 |
0.386 |
|
| 2018 |
Story-Roller E, Lamichhane G. 803. Overcoming β-Lactam Resistance in Mycobacterium abscessus Open Forum Infectious Diseases. 5: S288-S288. DOI: 10.1093/Ofid/Ofy210.810 |
0.375 |
|
| 2018 |
Tolufashe GF, Halder AK, Ibeji CU, Lawal MM, Ntombela T, Govender T, Maguire GEM, Lamichhane G, Kruger HG, Honarparvar B. Inhibition of Mycobacterium tuberculosis
L,D-Transpeptidase 5 by Carbapenems: MD and QM/MM Mechanistic Studies Chemistryselect. 3: 13603-13612. DOI: 10.1002/slct.201803184 |
0.589 |
|
| 2017 |
Kumar P, Chauhan V, Silva JRA, Lameira J, d'Andrea F, Li S, Ginell SL, Freundlich JS, Alves CN, Bailey S, Cohen KA, Lamichhane G. Mycobacterium abscessus L,D-transpeptidases are susceptible to inactivation by carbapenems and cephalosporins but not penicillins. Antimicrobial Agents and Chemotherapy. PMID 28760902 DOI: 10.1128/Aac.00866-17 |
0.65 |
|
| 2017 |
Azzali E, Machado D, Kaushik A, Vacondio F, Flisi S, Cabassi CS, Lamichhane G, Viveiros M, Costantino G, Pieroni M. Substituted N-phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery. Journal of Medicinal Chemistry. PMID 28749666 DOI: 10.1021/Acs.Jmedchem.7B00793 |
0.438 |
|
| 2017 |
Kaushik A, Ammerman NC, Tasneen R, Story-Roller E, Dooley KE, Dorman SE, Nuermberger EL, Lamichhane G. In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis. The Journal of Antimicrobial Chemotherapy. PMID 28575382 DOI: 10.1093/Jac/Dkx152 |
0.523 |
|
| 2017 |
Mattoo R, Lloyd EP, Kaushik A, Kumar P, Brunelle JL, Townsend CA, Lamichhane G. LdtMav2, a nonclassical transpeptidase and susceptibility of Mycobacterium avium to carbapenems. Future Microbiology. PMID 28555497 DOI: 10.2217/Fmb-2016-0208 |
0.627 |
|
| 2017 |
Bianchet MA, Pan YH, Basta LAB, Saavedra H, Lloyd EP, Kumar P, Mattoo R, Townsend CA, Lamichhane G. Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase LdtMt2 by biapenem and tebipenem. Bmc Biochemistry. 18: 8. PMID 28545389 DOI: 10.1186/S12858-017-0082-4 |
0.722 |
|
| 2017 |
Fakhar Z, Govender T, Maguire GEM, Lamichhane G, Walker RC, Kruger HG, Honarparvar B. Differential flap dynamics in l,d-transpeptidase2 from mycobacterium tuberculosis revealed by molecular dynamics. Molecular Biosystems. PMID 28480928 DOI: 10.1039/C7Mb00110J |
0.595 |
|
| 2017 |
Njire M, Wang N, Wang B, Tan Y, Cai X, Liu Y, Mugweru J, Guo J, Hameed HMA, Tan S, Liu J, Yew WW, Nuermberger E, Lamichhane G, Liu J, et al. Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. PMID 28438933 DOI: 10.1128/Aac.00070-17 |
0.536 |
|
| 2017 |
Kaushik A, Gupta C, Fisher S, Story-Roller E, Galanis C, Parrish N, Lamichhane G. Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus. Future Microbiology. PMID 28326811 DOI: 10.2217/Fmb-2016-0234 |
0.379 |
|
| 2017 |
Dey RJ, Dey B, Zheng Y, Cheung LS, Zhou J, Sayre D, Kumar P, Guo H, Lamichhane G, Sintim HO, Bishai WR. Inhibition of innate immune cytosolic surveillance by an M. tuberculosis phosphodiesterase. Nature Chemical Biology. 13: 210-217. PMID 28106876 DOI: 10.1038/Nchembio.2254 |
0.781 |
|
| 2017 |
Kumar P, Kaushik A, Bell D, Chauhan V, Xia F, Stevens RL, Lamichhane G. Mutation in an unannotated protein confers carbapenem resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. PMID 28069655 DOI: 10.1128/Aac.02234-16 |
0.638 |
|
| 2017 |
Fakhar Z, Govender T, Lamichhane G, Maguire GE, Kruger HG, Honarparvar B. Computational model for the acylation step of the β-lactam ring: Potential application for l,d-transpeptidase 2 in mycobacterium tuberculosis Journal of Molecular Structure. 1128: 94-102. DOI: 10.1016/J.Molstruc.2016.08.049 |
0.613 |
|
| 2016 |
Islam MM, Hameed HM, Mugweru J, Chhotaray C, Wang C, Tan Y, Liu J, Li X, Tan S, Ojima I, Yew WW, Nuermberger E, Lamichhane G, Zhang T. Drug resistance mechanisms and novel drug targets for tuberculosis therapy. Journal of Genetics and Genomics = Yi Chuan Xue Bao. PMID 28117224 DOI: 10.1016/J.Jgg.2016.10.002 |
0.465 |
|
| 2016 |
Kumar P, Kaushik A, Lloyd EP, Li SG, Mattoo R, Ammerman NC, Bell DT, Perryman AL, Zandi TA, Ekins S, Ginell SL, Townsend CA, Freundlich JS, Lamichhane G. Non-classical transpeptidases yield insight into new antibacterials. Nature Chemical Biology. PMID 27820797 DOI: 10.1038/Nchembio.2237 |
0.611 |
|
| 2016 |
Jaganath D, Lamichhane G, Shah M. Carbapenems against Mycobacterium tuberculosis: a review of the evidence. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease. 20: 1436-1447. PMID 27776583 DOI: 10.5588/Ijtld.16.0498 |
0.582 |
|
| 2016 |
Pelly S, Winglee K, Xia F, Stevens RL, Bishai WR, Lamichhane G. REMap: Operon map of M. tuberculosis based on RNA sequence data. Tuberculosis (Edinburgh, Scotland). 99: 70-80. PMID 27450008 DOI: 10.1016/J.Tube.2016.04.010 |
0.646 |
|
| 2016 |
Kaushik A, Heuer AM, Bell DT, Culhane JC, Ebner DC, Parrish N, Ippoliti JT, Lamichhane G. An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria. Bioorganic & Medicinal Chemistry Letters. PMID 27329794 DOI: 10.1016/J.Bmcl.2016.06.019 |
0.45 |
|
| 2016 |
Makafe GG, Cao Y, Tan Y, Julius M, Liu Z, Wang C, Njire MM, Cai X, Liu T, Wang B, Pang W, Tan S, Zhang B, Yew WW, Lamichhane G, et al. Oxazolidinone Resistance in Mycobacterium tuberculosis: What is the Role of Cys154Arg Mutation in the Ribosomal Protein L3? Antimicrobial Agents and Chemotherapy. PMID 26953211 DOI: 10.1128/Aac.00152-16 |
0.429 |
|
| 2016 |
Pelly S, Winglee K, Xia F, Stevens RL, Bishai WR, Lamichhane G. REMap: Operon map of M. tuberculosis based on RNA sequence data Tuberculosis. 99: 70-80. DOI: 10.1016/j.tube.2016.04.010 |
0.617 |
|
| 2015 |
Fakhar Z, Naiker S, Alvez CN, Govender T, Maguire GE, Lameira J, Lamichhane G, Kruger HG, Honarparvar B. A Comparative Modeling and Molecular Docking Study on Mycobacterium Tuberculosis Targets Involved in Peptidoglycan Biosynthesis. Journal of Biomolecular Structure & Dynamics. 1-42. PMID 26612108 DOI: 10.1080/07391102.2015.1117397 |
0.653 |
|
| 2015 |
Brammer Basta LA, Ghosh A, Pan Y, Jean J, Lloyd EP, Townsend CA, Lamichhane G, Bianchet MA. Loss of a functionally and structurally distinct L,D-transpeptidase, LdtMt5, compromises cell wall integrity in Mycobacterium tuberculosis. The Journal of Biological Chemistry. PMID 26304120 DOI: 10.1074/Jbc.M115.660753 |
0.528 |
|
| 2015 |
Kaushik A, Makkar N, Pandey P, Parrish N, Singh U, Lamichhane G. Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus. Antimicrobial Agents and Chemotherapy. 59: 6561-7. PMID 26259792 DOI: 10.1128/Aac.01158-15 |
0.515 |
|
| 2015 |
Alyahya SA, Nolan ST, Smith CM, Bishai WR, Sadoff J, Lamichhane G. Immunogenicity without Efficacy of an Adenoviral Tuberculosis Vaccine in a Stringent Mouse Model for Immunotherapy during Treatment. Plos One. 10: e0127907. PMID 25996375 DOI: 10.1371/Journal.Pone.0127907 |
0.675 |
|
| 2015 |
Silva JR, Bishai WR, Govender T, Lamichhane G, Maguire GE, Kruger HG, Lameira J, Alves CN. Targeting the cell wall of Mycobacterium tuberculosis: a molecular modeling investigation of the interaction of imipenem and meropenem with L,D-transpeptidase 2. Journal of Biomolecular Structure & Dynamics. 1-14. PMID 25762064 DOI: 10.1080/07391102.2015.1029000 |
0.72 |
|
| 2015 |
Moraes GL, Gomes GC, Monteiro de Sousa PR, Alves CN, Govender T, Kruger HG, Maguire GE, Lamichhane G, Lameira J. Structural and functional features of enzymes of Mycobacterium tuberculosis peptidoglycan biosynthesis as targets for drug development. Tuberculosis (Edinburgh, Scotland). 95: 95-111. PMID 25701501 DOI: 10.1016/J.Tube.2015.01.006 |
0.699 |
|
| 2014 |
Dutta NK, Bandyopadhyay N, Veeramani B, Lamichhane G, Karakousis PC, Bader JS. Systems biology-based identification of Mycobacterium tuberculosis persistence genes in mouse lungs. Mbio. 5. PMID 24549847 DOI: 10.1128/Mbio.01066-13 |
0.556 |
|
| 2014 |
Schoonmaker MK, Bishai WR, Lamichhane G. Nonclassical transpeptidases of Mycobacterium tuberculosis alter cell size, morphology, the cytosolic matrix, protein localization, virulence, and resistance to β-lactams. Journal of Bacteriology. 196: 1394-402. PMID 24464457 DOI: 10.1128/Jb.01396-13 |
0.751 |
|
| 2012 |
Erdemli SB, Gupta R, Bishai WR, Lamichhane G, Amzel LM, Bianchet MA. Targeting the cell wall of Mycobacterium tuberculosis: structure and mechanism of L,D-transpeptidase 2. Structure (London, England : 1993). 20: 2103-15. PMID 23103390 DOI: 10.1016/J.Str.2012.09.016 |
0.717 |
|
| 2012 |
Sarker M, Talcott C, Madrid P, Chopra S, Bunin BA, Lamichhane G, Freundlich JS, Ekins S. Combining cheminformatics methods and pathway analysis to identify molecules with whole-cell activity against Mycobacterium tuberculosis. Pharmaceutical Research. 29: 2115-27. PMID 22477069 DOI: 10.1007/S11095-012-0741-5 |
0.486 |
|
| 2012 |
Pelly S, Bishai WR, Lamichhane G. A screen for non-coding RNA in Mycobacterium tuberculosis reveals a cAMP-responsive RNA that is expressed during infection. Gene. 500: 85-92. PMID 22446041 DOI: 10.1016/J.Gene.2012.03.044 |
0.695 |
|
| 2011 |
Lamichhane G. Mycobacterium tuberculosis response to stress from reactive oxygen and nitrogen species. Frontiers in Microbiology. 2: 176. PMID 21904537 DOI: 10.3389/Fmicb.2011.00176 |
0.392 |
|
| 2011 |
Lamichhane G, Freundlich JS, Ekins S, Wickramaratne N, Nolan ST, Bishai WR. Essential metabolites of Mycobacterium tuberculosis and their mimics. Mbio. 2: e00301-10. PMID 21285434 DOI: 10.1128/Mbio.00301-10 |
0.717 |
|
| 2011 |
Wolschendorf F, Ackart D, Shrestha TB, Hascall-Dove L, Nolan S, Lamichhane G, Wang Y, Bossmann SH, Basaraba RJ, Niederweis M. Copper resistance is essential for virulence of Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America. 108: 1621-6. PMID 21205886 DOI: 10.1073/Pnas.1009261108 |
0.345 |
|
| 2011 |
Lamichhane G. Novel targets in M. tuberculosis: search for new drugs. Trends in Molecular Medicine. 17: 25-33. PMID 21071272 DOI: 10.1016/J.Molmed.2010.10.004 |
0.54 |
|
| 2010 |
Nolan ST, Lamichhane G. Protective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection. Plos One. 5: e13773. PMID 21048936 DOI: 10.1371/Journal.Pone.0013773 |
0.518 |
|
| 2010 |
Converse PJ, Eisenach KD, Theus SA, Nuermberger EL, Tyagi S, Ly LH, Geiman DE, Guo H, Nolan ST, Akar NC, Klinkenberg LG, Gupta R, Lun S, Karakousis PC, Lamichhane G, et al. The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol models. Plos One. 5: e10289. PMID 20422019 DOI: 10.1371/Journal.Pone.0010289 |
0.713 |
|
| 2010 |
Dutta NK, Mehra S, Didier PJ, Roy CJ, Doyle LA, Alvarez X, Ratterree M, Be NA, Lamichhane G, Jain SK, Lacey MR, Lackner AA, Kaushal D. Genetic requirements for the survival of tubercle bacilli in primates. The Journal of Infectious Diseases. 201: 1743-52. PMID 20394526 DOI: 10.1086/652497 |
0.815 |
|
| 2010 |
Gupta R, Lavollay M, Mainardi JL, Arthur M, Bishai WR, Lamichhane G. The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin. Nature Medicine. 16: 466-9. PMID 20305661 DOI: 10.1038/Nm.2120 |
0.743 |
|
| 2010 |
Olaleye O, Raghunand TR, Bhat S, He J, Tyagi S, Lamichhane G, Gu P, Zhou J, Zhang Y, Grosset J, Bishai WR, Liu JO. Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets. Chemistry & Biology. 17: 86-97. PMID 20142044 DOI: 10.1016/J.Chembiol.2009.12.014 |
0.745 |
|
| 2009 |
Davis SL, Be NA, Lamichhane G, Nimmagadda S, Pomper MG, Bishai WR, Jain SK. Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals. Plos One. 4: e6297. PMID 19606217 DOI: 10.1371/Journal.Pone.0006297 |
0.813 |
|
| 2009 |
Agarwal N, Lamichhane G, Gupta R, Nolan S, Bishai WR. Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase. Nature. 460: 98-102. PMID 19516256 DOI: 10.1038/Nature08123 |
0.718 |
|
| 2009 |
Alahari A, Alibaud L, Trivelli X, Gupta R, Lamichhane G, Reynolds RC, Bishai WR, Guerardel Y, Kremer L. Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis. Molecular Microbiology. 71: 1263-77. PMID 19183278 DOI: 10.1111/J.1365-2958.2009.06604.X |
0.723 |
|
| 2009 |
Converse PJ, Karakousis PC, Klinkenberg LG, Kesavan AK, Ly LH, Allen SS, Grosset JH, Jain SK, Lamichhane G, Manabe YC, McMurray DN, Nuermberger EL, Bishai WR. Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models. Infection and Immunity. 77: 1230-7. PMID 19103767 DOI: 10.1128/Iai.01117-08 |
0.691 |
|
| 2009 |
Be NA, Lamichhane G, Grosset J. Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system. (Journal of Infectious Diseases (2008) 198, (1520-1528)) Journal of Infectious Diseases. 199: 290. DOI: 10.1086/596032 |
0.765 |
|
| 2008 |
Be NA, Lamichhane G, Grosset J, Tyagi S, Cheng QJ, Kim KS, Bishai WR, Jain SK. Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system. The Journal of Infectious Diseases. 198: 1520-8. PMID 18956986 DOI: 10.1086/592447 |
0.825 |
|
| 2008 |
Jain SK, Lamichhane G, Nimmagadda S, Pomper MG, Bishai WR. Antibiotic treatment of tuberculosis: Old problems, new solutions Microbe. 3: 285-292. DOI: 10.1128/Microbe.3.285.1 |
0.705 |
|
| 2007 |
Jain SK, Hernandez-Abanto SM, Cheng QJ, Singh P, Ly LH, Klinkenberg LG, Morrison NE, Converse PJ, Nuermberger E, Grosset J, McMurray DN, Karakousis PC, Lamichhane G, Bishai WR. Accelerated detection of Mycobacterium tuberculosis genes essential for bacterial survival in guinea pigs, compared with mice. The Journal of Infectious Diseases. 195: 1634-42. PMID 17471433 DOI: 10.1086/517526 |
0.726 |
|
| 2007 |
Lamichhane G, Bishai W. Defining the 'survivasome' of Mycobacterium tuberculosis. Nature Medicine. 13: 280-2. PMID 17342137 DOI: 10.1038/Nm0307-280 |
0.734 |
|
| 2006 |
Lamichhane G, Raghunand TR, Morrison NE, Woolwine SC, Tyagi S, Kandavelou K, Bishai WR. Deletion of a Mycobacterium tuberculosis proteasomal ATPase homologue gene produces a slow-growing strain that persists in host tissues. The Journal of Infectious Diseases. 194: 1233-40. PMID 17041849 DOI: 10.1086/508288 |
0.736 |
|
| 2006 |
Jain SK, Paul-Satyaseela M, Lamichhane G, Kim KS, Bishai WR. Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis. The Journal of Infectious Diseases. 193: 1287-95. PMID 16586367 DOI: 10.1086/502631 |
0.744 |
|
| 2005 |
Lamichhane G, Tyagi S, Bishai WR. Designer arrays for defined mutant analysis to detect genes essential for survival of Mycobacterium tuberculosis in mouse lungs. Infection and Immunity. 73: 2533-40. PMID 15784600 DOI: 10.1128/Iai.73.4.2533-2540.2005 |
0.703 |
|
| 2004 |
Karakousis PC, Yoshimatsu T, Lamichhane G, Woolwine SC, Nuermberger EL, Grosset J, Bishai WR. Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. The Journal of Experimental Medicine. 200: 647-57. PMID 15353557 DOI: 10.1084/Jem.20040646 |
0.741 |
|
| 2004 |
Yoder MA, Lamichhane G, Bishai WR. Cavitary pulmonary tuberculosis: The Holy Grail of disease transmission Current Science. 86: 74-81. |
0.307 |
|
| 2003 |
Lamichhane G, Zignol M, Blades NJ, Geiman DE, Dougherty A, Grosset J, Broman KW, Bishai WR. A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America. 100: 7213-8. PMID 12775759 DOI: 10.1073/Pnas.1231432100 |
0.642 |
|
| Show low-probability matches. |
